The Company is a Korea-based company that mainly engaged in the manufacturing and sale of pharmaceuticals. The Company manufactures and sells circulation system drugs, digestion drugs, anti-inflammatory analgesic, other prescription drug for treating hypertension, hyperlipidemia, peptic ulcer, indigestion, osteoarthritis, pain, and dementia, among others. The Company distributes its products within the domestic market and to overseas markets. The Company was established on December 28, 1992. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on February 12, 2018.
Headquarters
Korea Arlico Pharm Bildg, 7-21, Baumoe-Ro 27-Gil, Seocho-Gu
Seoul; Seoul;
Contact Details: Purchase the Korea Arlico Pharm Co.,Ltd. report to view the information.
Website: http://www.arlico.co.kr/
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service